| Financial Year |
March 31 2023 |
| Monetary Funds |
206,771,461.66 |
| Held-for-trading Financial Assets |
423,685,566.98 |
| Notes Receivable |
3,735,971.10 |
| Accounts Receivable |
400,432,515.53 |
| Advances to Suppliers |
13,235,130.50 |
| Other Receivables |
11,908,847.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
67,173,181.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,187,064.28 |
| Total Current Assets |
1,139,454,717.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,011,664.95 |
| Investment Properties |
46,956,880.96 |
| Fixed Assetes |
78,413,608.28 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,196,418.94 |
| R&D expenses |
-- |
| Goodwill |
19,639,289.85 |
| Long-Term Deferred and Prepaid Expenses |
10,658,159.01 |
| Deferred Income Tax Assets |
17,813,441.06 |
| Other Non-Current Assets |
41,519,551.21 |
| Sub-Total of Non-Current Assets |
311,141,692.17 |
| Total Assets |
1,450,596,409.43 |
| Short-Term Loans |
1,118,923.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
46,215,805.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,387,673.78 |
| Taxes Payable |
4,756,258.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,805,284.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,255,299.98 |
| Other Current Liabilities |
16,332,825.64 |
| Sub-Total of Current Liabilities |
314,078,230.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
55,231.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,844,010.49 |
| Total Liabilities |
330,922,240.91 |
| Paid-In Capital(Or Share Stock) |
60,000,000.00 |
| Capital Surplus |
723,631,367.01 |
| Surplus Reserve |
30,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
301,729,275.84 |
| Minority Stockholder's Interest |
3,778,981.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,115,895,186.97 |
| Owner's Equity（Stockholder's Equity） |
1,119,674,168.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,450,596,409.43 |
